Wang, C., Zhang, J., Li, W., Zhong, X., Zhu, X., Cheng, Y., Qian, H., Tang, X., Li, Y., Huang, M., Zhang, Z., Guo, W. (2026). Regorafenib combined with trifluridine/tipiracil versus regorafenib monotherapy in refractory metastatic colorectal cancer (FDZL-REGOT): A randomized phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.157